论文部分内容阅读
目的探讨百令胶囊联合应用低分子肝素治疗儿童原发性肾病综合征的临床疗效。方法 43例原发性肾病综合征患儿,作为观察组,采用百令胶囊联合低分子肝素进行治疗;并选取同期的43例原发性肾病综合征患儿,作为对照组,采用常规激素加低分子肝素进行治疗。观察两组患儿的24小时尿蛋白(24 h Upro)、总胆固醇(TC)、血浆白蛋白(ALB)、血尿素氮(BUN)、血清肌酐(Scr)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)变化及临床治疗效果。结果经8周治疗,观察组治疗后的24 h Upro、TC、ALB、APTT、FIB改善程度均优于对照组(P<0.05);两组治疗后BUN、Scr、PT比较差异无统计学意义(P>0.05);观察组总有效率为93.02%,明显高于对照组的72.09%(P<0.05)。结论百令胶囊联合应用低分子肝素治疗儿童原发性肾病综合征具有较为显著的效果,可改善患儿临床症状,临床推广应用价值较高。
Objective To investigate the clinical effect of Bailing capsule combined with low molecular weight heparin on children with primary nephrotic syndrome. Methods Forty-three children with primary nephrotic syndrome were treated with Bailing capsule and low-molecular-weight heparin as the observation group. Forty-three children with primary nephrotic syndrome were selected as the control group, Low molecular weight heparin for treatment. The 24-hour urine protein (24 h), total cholesterol (TC), serum albumin (ALB), blood urea nitrogen (BUN), serum creatinine (Scr), prothrombin time (PT) Activated partial thromboplastin time (APTT), fibrinogen (FIB) changes and clinical treatment. Results After 8 weeks of treatment, the levels of Upro, TC, ALB, APTT and FIB in observation group were better than those in control group at 24 h after treatment (P <0.05). There was no significant difference in BUN, Scr and PT between two groups (P> 0.05). The total effective rate in the observation group was 93.02%, which was significantly higher than that in the control group (72.09%, P <0.05). Conclusion Bailing capsule combined with low molecular weight heparin treatment of children with primary nephrotic syndrome has a significant effect, can improve clinical symptoms in children, clinical application of higher value.